Inspiration Healthcare (LSE:IHC) delivered a strong financial performance in FY26, marking a transition from business stabilisation to executing its long-term growth strategy. The company is focusing on strengthening its neonatal care franchise, expanding its international footprint and enhancing operational efficiency, while improved cash generation and tighter financial discipline continue to support its evolution into a more focused, higher-growth medical technology business.
Revenue and cash flow strengthen as SLE division drives performance
Revenue increased 24% to £47.5 million during the year, while gross profit rose 27% to £20.8 million. Adjusted EBITDA reached £2.8 million, operating cash inflow improved to £7.5 million and net debt was reduced by 39%, reflecting stronger financial execution.
Growth was led by the company’s SLE neonatal business, which benefited from significant export contracts alongside healthy underlying demand. Following the year-end, Inspiration Healthcare also completed the transfer of its infusion business to Micrel, a move that further concentrates the group’s resources on neonatal care and supports management’s confidence in its FY27 prospects.
Cash generation improves despite ongoing profitability challenges
The company’s outlook is supported by stronger underlying financial performance, particularly the significant recovery in operating and free cash flow during 2026. However, Inspiration Healthcare continues to report net losses, and investors remain mindful of earnings volatility seen in previous years.
From a market perspective, technical indicators remain weak, with a bearish trend and negative MACD, although oversold conditions may suggest scope for a recovery. Valuation metrics also remain limited by a negative price-to-earnings ratio, while no dividend yield has been reported.
About Inspiration Healthcare
Inspiration Healthcare Group is a UK-based medical technology company specialising in equipment for neonatal intensive care. Its portfolio includes advanced ventilators, respiratory support systems and single-use medical devices designed to care for premature and critically ill newborns. The company supplies hospitals directly across the UK and Ireland while serving more than 75 countries through an international distribution network, with manufacturing operations based in Croydon and a facility in Florida.
Alongside its domestic infusion therapy distribution business, Inspiration Healthcare is increasingly concentrating its strategy on neonatal care technologies, reinforcing its position in a specialist healthcare market with significant long-term demand.
Leave a Reply